Niagen Bioscience(DE:OCD1)
€1.89+0.27 (+1.61%)
DE:OCD1
Niagen Bioscience Revenue
€1.89
At close:+0.27 (+1.61%)
Niagen Bioscience (OCD1) Revenue
2 Followers
Niagen Bioscience Revenue
Niagen Bioscience had a revenue of 27.19M in the quarter ending Sep 30, 2026, with -8.71%. This bring the company's revenue in the last twelve months to 122.29M, Decreased 5.26%. In the fiscal year ending Dec 31, 2025, Niagen Bioscience had annual revenue of 129.42M with 29.95% growth.
- Revenue (ttm)
- 122.29M
- Revenue Growth
- -6.71%
- P/S Ratio
- 1.19
- Revenue/Employee
- EUR 1,106,179
- Employees
- 117
- Market Cap
- EUR 153.45M
Revenue Chart
Niagen Bioscience Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 129.42M | 29.83M | 29.95% |
| Dec 31, 2024 | 99.60M | 16.03M | 19.18% |
| Dec 31, 2023 | 83.57M | 11.52M | 15.99% |
| Dec 31, 2022 | 72.05M | 4.60M | 6.82% |
| Dec 31, 2021 | 67.45M | 8.19M | 13.82% |
| Dec 31, 2020 | 59.26M | 12.97M | 28.01% |
| Dec 31, 2019 | 46.29M | 14.73M | 46.69% |
| Dec 31, 2018 | 31.56M | 10.36M | 48.85% |
| Dec 31, 2017 | 21.20M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.